|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM301968853 |
003 |
DE-627 |
005 |
20231225105727.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2019 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.3928/23258160-20190905-18
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1006.xml
|
035 |
|
|
|a (DE-627)NLM301968853
|
035 |
|
|
|a (NLM)31589767
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Obeid, Anthony
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Macular Hole Following Subretinal Tissue Plasminogen Activator for Submacular Hemorrhage Secondary to Neovascular AMD
|
264 |
|
1 |
|c 2019
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 26.06.2020
|
500 |
|
|
|a Date Revised 26.06.2020
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright 2019, SLACK Incorporated.
|
520 |
|
|
|a A full-thickness macular hole (FTMH) is a rare sequela to submacular hemorrhage. Herein, the authors report a case of an 80-year-old man actively being treated for neovascular age-related macular degeneration who presented with sudden vision loss in the right eye. Examination with optical coherence tomography (OCT) imaging revealed submacular hemorrhage. The patient underwent vitrectomy with subretinal tissue plasminogen activator (tPA) with no intraoperative complications. Dilated fundus examination and OCT imaging revealed a FTMH at postop week 1. Possible causes for MH development include the submacular hemorrhage itself and subretinal administration of the tPA infusion. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:e257-e259.]
|
650 |
|
4 |
|a Case Reports
|
650 |
|
4 |
|a Journal Article
|
650 |
|
7 |
|a Fibrinolytic Agents
|2 NLM
|
650 |
|
7 |
|a Tissue Plasminogen Activator
|2 NLM
|
650 |
|
7 |
|a EC 3.4.21.68
|2 NLM
|
700 |
1 |
|
|a Talcott, Katherine E
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ali, Ferhina S
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gao, Xinxiao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sioufi, Kareem
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wibbelsman, Turner D
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ho, Allen C
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Ophthalmic surgery, lasers & imaging retina
|d 2013
|g 50(2019), 9 vom: 01. Sept., Seite e257-e259
|w (DE-627)NLM224956647
|x 2325-8179
|7 nnns
|
773 |
1 |
8 |
|g volume:50
|g year:2019
|g number:9
|g day:01
|g month:09
|g pages:e257-e259
|
856 |
4 |
0 |
|u http://dx.doi.org/10.3928/23258160-20190905-18
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_31
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_63
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_69
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_90
|
912 |
|
|
|a GBV_ILN_91
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_135
|
912 |
|
|
|a GBV_ILN_136
|
912 |
|
|
|a GBV_ILN_151
|
912 |
|
|
|a GBV_ILN_181
|
912 |
|
|
|a GBV_ILN_203
|
912 |
|
|
|a GBV_ILN_217
|
912 |
|
|
|a GBV_ILN_235
|
912 |
|
|
|a GBV_ILN_289
|
912 |
|
|
|a GBV_ILN_294
|
912 |
|
|
|a GBV_ILN_297
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_352
|
912 |
|
|
|a GBV_ILN_674
|
912 |
|
|
|a GBV_ILN_676
|
912 |
|
|
|a GBV_ILN_688
|
912 |
|
|
|a GBV_ILN_698
|
912 |
|
|
|a GBV_ILN_721
|
912 |
|
|
|a GBV_ILN_737
|
912 |
|
|
|a GBV_ILN_791
|
912 |
|
|
|a GBV_ILN_812
|
951 |
|
|
|a AR
|
952 |
|
|
|d 50
|j 2019
|e 9
|b 01
|c 09
|h e257-e259
|